Edition:
United Kingdom

Cue Biopharma Inc (CUE.OQ)

CUE.OQ on NASDAQ Stock Exchange Capital Market

7.25USD
18 Jun 2019
Change (% chg)

-- (--)
Prev Close
$7.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
25,076
52-wk High
$13.39
52-wk Low
$4.16

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.37 -0.544
FY 2018 Dec '18 0.33 -0.575
Sep '18 0.45 -0.624
Jun '18 0.17 -0.363
Mar '18 0.19 -0.373
FY 2017 Dec '17 0.00 -0.627
Sep '17 0.00 -0.302
Jun '17 0.00 -0.195
Mar '17 0.00 -0.315
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Earnings (per share)
Quarter Ending Jun-19 1 -0.40 -0.40 -0.40 --
Quarter Ending Sep-19 1 -0.41 -0.41 -0.41 --
Year Ending Dec-19 1 -1.63 -1.63 -1.63 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.30 32.55
P/E High - Last 5 Yrs. -- 147.69 48.11
P/E Low - Last 5 Yrs. -- 47.94 23.41
Beta -- 1.08 0.87
Price to Sales (TTM) -- 49.50 8.43
Price to Book (MRQ) -- 10.13 5.27
Price to Tangible Book (MRQ) -- 13.74 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions -- 3.71 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.71
Payout Ratio(TTM) -- 7.02 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 49.05 8.04
Sales - 5 Yr. Growth Rate -- 22.77 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.32 48.19
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 11.97 10.46
Capital Spending - 5 Yr. Growth Rate -- 9.11 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) -- 3.57 2.98
LT Debt to Equity (MRQ) -- 18.62 11.35
Total Debt to Equity (MRQ) -- 31.29 16.04
Interest Coverage (TTM) -- -43.11 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.27 52.39
Gross Margin - 5 Yr. Avg. -- 60.50 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.91 12.41
Operating Margin (TTM) -- -184.93 5.67
Operating Margin - 5 Yr. Avg. -- -127.41 8.00
Pre-Tax Margin (TTM) -- -175.62 4.69
Pre-Tax Margin - 5 Yr. Avg. -- -133.20 8.28
Net Profit Margin (TTM) -- -182.34 1.42
Net Profit Margin - 5 Yr. Avg. -- -137.59 4.69
Effective Tax Rate (TTM) -- 22.46 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,653,013 819,627,197
Net Income/Employee (TTM) -- 513,435 92,777,164
Receivable Turnover (TTM) -- 6.28 5.82
Inventory Turnover (TTM) -- 1.89 3.42
Asset Turnover (TTM) -- 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.37 10.65
Return on Assets - 5 Yr. Avg. -- 5.47 11.77
Return on Investment (TTM) -- 8.90 13.82
Return on Investment - 5 Yr. Avg. -- 6.78 15.32
Return on Equity (TTM) -- 10.04 15.24
Return on Equity - 5 Yr. Avg. -- 8.36 16.41
Note: Units in Millions of US Dollars

Performance for Cue Biopharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 99
13 Week -- -- -- 95
26 Week -- -- -- 97
52 Week -- -- -- 70
YTD -- -- -- 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 21.76%
# of Holders: 65
Total Shares Held: 4,523,043
3 Mo. Net Change: 226,001
# New Positions: 9
# Closed Positions: 3
# Increased Positions: 20
# Reduced Positions: 27
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.